271 research outputs found
Environmentally Induced Oxidative Stress and Disruption of Brain Thyroid Hormone Homeostasis in Autism Spectrum Disorders
In memory of my son and a budding neuroscientist, Zachary L. Sulkowski, B
Effects of confinement and crowding on folding of model proteins
We perform molecular dynamics simulations for a simple coarse-grained model
of crambin placed inside of a softly repulsive sphere of radius R. The
confinement makes folding at the optimal temperature slower and affects the
folding scenarios, but both effects are not dramatic. The influence of crowding
on folding are studied by placing several identical proteins within the sphere,
denaturing them, and then by monitoring refolding. If the interactions between
the proteins are dominated by the excluded volume effects, the net folding
times are essentially like for a single protein. An introduction of
inter-proteinic attractive contacts hinders folding when the strength of the
attraction exceeds about a half of the value of the strength of the single
protein contacts. The bigger the strength of the attraction, the more likely is
the occurrence of aggregation and misfolding
A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency
SARS-CoV-2, primarily considered a respiratory virus, is increasingly recognized as having gastrointestinal aspects based on its presence in the gastrointestinal (GI) tract and feces. SARS-CoV-2 uses as a receptor angiotensin-converting enzyme 2 (ACE-2), a critical member of the renin-angiotensin-aldosterone system (RAAS) involved in the regulation of blood pressure and fluid system. In addition to the systemic endocrine functions, RAAS components are also involved in intracrine and organ-specific local functions. The angiotensin-converting enzyme 2 (ACE-2) is a key component of RAAS and a receptor for SARS-CoV-2. It is expressed in many tissues with gastrointestinal (GI) tract ACE-2 levels far exceeding those in the respiratory tract. SARS-CoV-2 binding to its receptor results in a deficiency of ACE-2 activity in endocrine, intracrine, and local lung and GI tract ACE-2. The local ACE-2 has different organ-specific functions, including hypertension-independent activities; dysregulations of these functions may contribute to multiorgan COVID-19 pathology, its severity, long-term effects, and mortality. We review supporting evidence from this standpoint. Notably, COVID-19 comorbidities involving hypertension, obesity, heart disease, kidney disease, and diabetes are associated with gastrointestinal problems and display ACE-2 deficits. While RAAS inhibitors target both endocrine and intracrine ACE-2 activity, the deficit of the local ACE-2 activity in the lungs and more so in the gut have not been targeted. Consequently, the therapeutic approach to COVID-19 should be carefully reconsidered. Ongoing clinical trials testing oral probiotic bound ACE-2 delivery are promising
BSDB: the biomolecule stretching database
We describe the Biomolecule Stretching Data Base that has been recently set up at http://www.ifpan.edu.pl/BSDB/. It provides information about mechanostability of proteins. Its core is based on simulations of stretching of 17 134 proteins within a structure-based model. The primary information is about the heights of the maximal force peaks, the force–displacement patterns, and the sequencing of the contact-rupturing events. We also summarize the possible types of the mechanical clamps, i.e. the motifs which are responsible for a protein's resistance to stretching
KnotProt: a database of proteins with knots and slipknots.
The protein topology database KnotProt, http://knotprot.cent.uw.edu.pl/, collects information about protein structures with open polypeptide chains forming knots or slipknots. The knotting complexity of the cataloged proteins is presented in the form of a matrix diagram that shows users the knot type of the entire polypeptide chain and of each of its subchains. The pattern visible in the matrix gives the knotting fingerprint of a given protein and permits users to determine, for example, the minimal length of the knotted regions (knot's core size) or the depth of a knot, i.e. how many amino acids can be removed from either end of the cataloged protein structure before converting it from a knot to a different type of knot. In addition, the database presents extensive information about the biological functions, families and fold types of proteins with non-trivial knotting. As an additional feature, the KnotProt database enables users to submit protein or polymer chains and generate their knotting fingerprints
Expression of the apoptotic markers in normal breast epithelium, benign mammary dysplasia and in breast cancer
Apoptosis and proliferation are processes associated with the development and
progression of breast cancer. The sensitivity of tumour cells to the induction of
apoptosis depends on the balance between pro- and anti-apoptotic proteins.
The expression of Bak and Bcl-2 was examined using an immunohistochemical
method in 71 primary breast cancers. Furthermore, Bcl-2 and Bak were assessed
in the normal mammary gland as well as in benign mammary dysplasia adjacent
to breast cancer. Positive immunostaining for Bcl-2 was observed in 77.8% of
cases of normal breast epithelium (NBE), 93% of benign dysplasia without intraductal
proliferation (BBD) as well as in 94% of intraductal proliferative lesions of
the breast (BIPL). Expression of Bak was detected in 39% of cases of NBE, 45%
of BBD and in 67% of BIPL. In breast cancer Bcl-2 and Bak expression was found
in 83% and 70% of the cases studied, respectively. Increased Bcl-2 expression in
primary tumours significantly correlated with favourable prognostic factors, namely
pT1, G2 and lack of metastases to the regional lymph nodes (p < 0.01,
p < 0.03, p < 0.02, respectively). There were no relationships between Bak and
the clinicopathological features studied, but our results indicate changes in the
expression of Bak during breast cancer development and progression. It would
appear to be important to assess and compare pro- and anti-apoptotic proteins
between normal mammary gland, benign mammary dysplasia and the primary
tumours of breast cancer. This knowledge should be helpful in understanding
breast cancer development and progression
Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli
PURPOSE: Recent in vitro studies suggested that the autocrine leptin loop might contribute to breast cancer development by enhancing cell growth and survival. To evaluate whether the leptin system could become a target in breast cancer therapy, we examined the expression of leptin and its receptor (ObR) in primary and metastatic breast cancer and noncancer mammary epithelium. We also studied whether the expression of leptin/ObR in breast cancer can be induced by obesity-related stimuli, such as elevated levels of insulin, insulin-like growth factor-I (IGF-I), estradiol, or hypoxic conditions.
EXPERIMENTAL DESIGN: The expression of leptin and ObR was examined by immunohistochemistry in 148 primary breast cancers and 66 breast cancer metastases as well as in 90 benign mammary lesions. The effects of insulin, IGF-I, estradiol, and hypoxia on leptin and ObR mRNA expression were assessed by reverse transcription-PCR in MCF-7 and MDA-MB-231 breast cancer cell lines.
RESULTS: Leptin and ObR were significantly overexpressed in primary and metastatic breast cancer relative to noncancer tissues. In primary tumors, leptin positively correlated with ObR, and both biomarkers were most abundant in G3 tumors. The expression of leptin mRNA was enhanced by insulin and hypoxia in MCF-7 and MDA-MB-231 cells, whereas IGF-I and estradiol stimulated leptin mRNA only in MCF-7 cells. ObR mRNA was induced by insulin, IGF-I, and estradiol in MCF-7 cells and by insulin and hypoxia in MDA-MB-231 cells.
CONCLUSIONS: Leptin and ObR are overexpressed in breast cancer, possibly due to hypoxia and/or overexposure of cells to insulin, IGF-I, and/or estradiol
- …